APALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN TITAN: PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN RESPONSES

被引：0
|
作者：
Chowdhury, Simon
Bjartell, Anders
Agarwal, Neeraj
Chung, Byung Ha
Given, Robert W.
Pereira de Santana Gomes, Andrea J.
Merseburger, Axel S.
Ozguroglu, Mustafa
Juarez Soto, Alvaro
Uemura, Hirotsugu
Ye, Dingwei
Lopez-Gitlitz, Angela
Londhe, Anil
Mundle, Suneel
Larsen, Julie S.
McCarthy, Sharon
Chi, Kim N.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD10-11
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [1] A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
    Kwon, Daniel Hyuck-Min
    Friedlander, Terence
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [2] Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis
    Ye, Ding-Wei
    Uemura, Hirotsugu
    Chung, Byung Ha
    Suzuki, Hiroyoshi
    Mundle, Suneel
    Bhaumik, Amitabha
    Singh, Anildeep
    Chowdhury, Simon
    Agarwal, Neeraj
    Chi, Kim N.
    Huang, Jian
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (02) : 164 - 172
  • [3] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Chi, Kim N.
    Agarwal, Neeraj
    Bjartell, Anders
    Chung, Byung Ha
    Pereira de Santana Gomes, Andrea J.
    Given, Robert
    Juarez Soto, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Deprince, Kris
    Naini, Vahid
    Li, Jinhui
    Cheng, Shinta
    Yu, Margaret K.
    Zhang, Ke
    Larsen, Julie S.
    McCarthy, Sharon
    Chowdhury, Simon
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 13 - 24
  • [4] Use of Apalutamide for metastatic, castration-sensitive Prostate Cancer
    Thomas, C.
    UROLOGE, 2019, 58 (12): : 1496 - 1497
  • [5] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Sheridan M. Hoy
    Drugs, 2020, 80 : 1579 - 1585
  • [6] Apalutamide for the treatment of metastatic castration-sensitive prostate cancer
    Dror, Corinne Maurice
    Chi, Kim Nguyen
    FUTURE ONCOLOGY, 2020, 16 (35) : 2905 - 2916
  • [7] Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 661 - 661
  • [8] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2020, 80 (15) : 1579 - 1585
  • [9] Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide
    Lowentritt, Benjamin
    Pilon, Dominic
    Khilfeh, Ibrahim
    Rossi, Carmine
    Muser, Erik
    Kinkead, Frederic
    Waters, Dexter
    Ellis, Lorie
    Lefebvre, Patrick
    Brown, Gordon
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 253.e1 - 253.e9
  • [10] Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.
    Lowentritt, Benjamin
    Pilon, Dominic
    Khilfeh, Ibrahim
    Rossi, Carmine
    Muser, Erik
    Kinkead, Frederic
    Waters, Dexter
    Ellis, Lorie
    Lefebvre, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345